Tabula Rasa HealthCare Names April Gill Chief Commercial Officer
Tabula Rasa HealthCare, Inc.® (TRHC), a healthcare technology leader, has appointed April D. Gill as Chief Commercial Officer to enhance its commercialization strategy. With over 20 years of healthcare experience, Gill will lead TRHC in executing marketing, sales, and product strategies. Brian Adams, President and Interim CEO, emphasized her expertise in driving growth and client success. Previously, Gill held executive roles at Virgin Pulse and Welltok, focusing on value-based products and strategic initiatives. TRHC aims to optimize medication safety solutions, improving patient outcomes and reducing healthcare costs.
- Appointment of April D. Gill as Chief Commercial Officer, enhancing leadership.
- Gill brings over 20 years of healthcare experience, potentially driving growth.
- Focus on commercialization strategy may improve market reach and revenue.
- None.
MOORESTOWN, N.J., Nov. 1, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced the appointment of April D. Gill as Chief Commercial Officer. Ms. Gill has more than 20 years of experience in healthcare with a proven track record exceeding client satisfaction, sales, and profitability goals.
In this newly created role, Ms. Gill will oversee development and execution of TRHC's commercialization with broad responsibility for strategy, product, marketing, communications, sales, and account management activities.
"April is an accomplished executive with a wealth of healthcare expertise focused on commercialization efforts, client success, and business strategies to drive growth," said Brian Adams, President and Interim CEO of TRHC. "I am thrilled to welcome April to TRHC and look forward to working with her and the entire team as we advance our go-to-market strategy to take advantage of existing and emerging opportunities adjacent to our core PACE market."
Previously, Ms. Gill was EVP & General Manager Health Plans & Health Systems for Virgin Pulse (formerly Welltok) where she led development of value-based products, software, and services for the health plan and health system markets. Prior to that, she was Chief Strategy Officer & SVP Solution Management for Welltok with a focus on execution of strategic initiatives and leading a cross-functional team responsible for product, marketing, sales, and consumer experience.
"I am excited to join Tabula Rasa at this pivotal time in its history," said April Gill. "I am encouraged by TRHC's strong foundation and am looking forward to building a robust commercial organization to accelerate growth and advance the development of industry leading products and services for value-based markets."
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combating medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC's proprietary technology solutions, including MedWise®, improve patient outcomes and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and at-risk provider groups to help drive value-based care. For more information, visit tabularasahealthcare.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/tabula-rasa-healthcare-names-april-gill-chief-commercial-officer-301663577.html
SOURCE Tabula Rasa HealthCare, Inc.
FAQ
Who is the new Chief Commercial Officer of TRHC?
What is the main responsibility of April Gill at TRHC?
What was April Gill's experience before joining TRHC?
What are TRHC's goals with the new appointment?
What services does TRHC provide?
